AntibioticMech

clofazimine

CHEBI:3749 ·resolve ·ANTIMYCOBACTERIAL ·EXACT SEEDED

3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimycobacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients. — ChEBI

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

antibiotic without defined classificationARO:3000003

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC27H22Cl2N4
Charge0
Average mass473.407 Da
Monoisotopic mass472.12215 Da
SourceChEBI
InChIKeyWDQPAMHFFCXSNU-UHFFFAOYSA-N

SMILES

CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1

InChI

InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Drug registries

Identifiers that name a drug rather than a structure. One of these can cover a parent compound, its salts and its stereoisomers, which this corpus keeps as separate records, so it is not an equivalence of structure.

Patents and articles

Documents about this compound. A patent covers a class and an article covers a topic; neither identifies a structure.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
ARO ARO:3004012 clofazimine antibioticmech:aro-2f5364eabc 2026-08-30
CHEBI CHEBI:3749 clofazimine antibioticmech:chebi-fa5f5dc8e5 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

fluoroquinolone sensitive gyrA PROTEIN DIRECT_BINDING_TARGET

ARO:3000733

CARD/ARO database assertion; target organism, strain, and assay are not specified. ARO explicitly describes ligand binding to gyrase subunit A. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

fluoroquinolone sensitive gyrB PROTEIN DIRECT_BINDING_TARGET

ARO:3003261

CARD/ARO database assertion; target organism, strain, and assay are not specified. GyrB is asserted as the fluoroquinolone-sensitive subunit. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

Activity spectrum

Measured or curated activity against specific taxa. A number without a method is not an observation — every row here carries an assay.

242 observations · Browse all observations · Complete record (JSON.gz)

Observations 1–20 of 242

Activity observations
OrganismActivityMICDisk diffusionAssayStrainSample/genomeEvidence
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 — 18 source isolates
18 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 — 4366 source isolates
4366 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2020; not specified — 2 source isolates
2 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2020; not specified — 2 source isolates
2 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex INTERMEDIATE — — CRyPTIC DST; CLIRES2020; solid media — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2020; solid media — 32 source isolates
32 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2020; solid media — 63 source isolates
63 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2023; liquid media; MGIT; MGIT960 — 8 source isolates
8 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2023; liquid media; MGIT; MGIT960 — 858 source isolates
858 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2023; not specified — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2023; solid media — 7 source isolates
7 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2023; solid media — 4 source isolates
4 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE 0.12 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 1151 source isolates
1151 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE 0.12 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 217 source isolates
217 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE 0.12 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 257 source isolates
257 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE 0.25 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 410 source isolates
410 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE 0.25 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 160 source isolates
160 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE 0.25 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 101 source isolates
101 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT 0.5 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 113 source isolates
113 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT 0.5 mg/L — CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.25 mg/L — 54 source isolates
54 measurements
Evidence Page data (JSON.gz)

Resistance mechanisms

3 source-backed resistance determinants or associations, with ARO grounding where reported. Grouped by reported mechanism type.

ANTIBIOTIC_TARGET_ALTERATION 3
ANTIBIOTIC_TARGET_ALTERATION
DeterminantARO IDOrganismGene familiesEvidence
Mycobacterium tuberculosis Rv0678 with mutation conferring resistance to clofazimine ARO:3007852 not organism-specific —
  • ARO:3007852 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3004012 (clofazimine); database assertion, not a primary citation.)
Mycobacterium tuberculosis Rv2535c with mutation conferring resistance to bedaquiline ARO:3007692 not organism-specific —
  • ARO:3007692 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3004012 (clofazimine); database assertion, not a primary citation.)
Mycobacterium tuberculosis Rv2535c with mutation conferring resistance to clofazimine ARO:3009335 not organism-specific —
  • ARO:3009335 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3004012 (clofazimine); database assertion, not a primary citation.)

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (ARO, CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. RESEEDED_FROM_SOURCES 2026-09-10 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  6. RESEEDED_FROM_SOURCES 2026-09-26 · seed_from_sources

    Re-seeded; changed: activity_spectrum (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.

  7. RESEEDED_FROM_SOURCES 2026-10-05 · seed_from_sources

    Re-seeded; changed: activity_membership_collections (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (clofazimine) · CultureMech · NaturalProductMech · PathwayMech · TraitMech